Antitope is a privately-held biotechnology research company focused on the development of non-immunogenic protein therapeutics. The company was formed in Cambridge, UK in 2004 in order to advance previous research of the founders by developing proprietary technologies for immunogenicity prediction, antibody humanization and engineering therapeutic proteins. To date, we have entered into agreements with pharmaceutical and biotechnology companies worldwide to apply our technologies for the development of improved biologics.
Our services are tailored for each study to ensure project objectives are met or exceeded. Experienced project teams are assigned to each study focusing on progressing projects through to results in the minimum amount of time. Our clients uniformly judge us as professional and attentive partners who deliver quality results in a timely manner.